SpyGlass Pharma SGP SEC Filings

NASDAQ SGP
$28.93 -0.06 (-0.21%)
As of: Sep 4, 2026 · 2:23 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document SpyGlass Pharma, Inc. (SGP) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index